These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31727565)

  • 21. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?
    Ostensen M; Ramsey-Goldman R
    Drug Saf; 1998 Nov; 19(5):389-410. PubMed ID: 9825952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation.
    Janssen NM; Genta MS
    Arch Intern Med; 2000 Mar; 160(5):610-9. PubMed ID: 10724046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safety of rheumatic disease drugs at childbearing age].
    Zrour-Hassen S; Jguirim M; Aouam K; Korbaa W; Younes M; Bejia I; Touzi M; Bergaoui N
    Therapie; 2010; 65(5):465-73. PubMed ID: 21144482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medications in pregnancy and breastfeeding.
    Tosounidou S; Gordon C
    Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():68-76. PubMed ID: 32019728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological and immunosuppressive medications in pregnancy, breastfeeding and fertility in immune mediated diseases.
    Ibarra Barrueta O; García Martín E; López Sánchez P; Ramírez Herráiz E; Merino Bohórquez V; Ais Larisgoitia A
    Farm Hosp; 2023; 47(1):39-49. PubMed ID: 36710223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Translated article] Biological and immunosuppressive medications in pregnancy, breastfeeding and fertility in immune mediated diseases.
    Ibarra Barrueta O; García Martín E; López Sánchez P; Ramírez Herráiz E; Merino Bohórquez V; Ais Larisgoitia A
    Farm Hosp; 2023; 47(1):T39-T49. PubMed ID: 36732114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical treatment of adolescents with rheumatic disease.
    Hollister JR
    Adolesc Med; 1998 Feb; 9(1):163-70, vii. PubMed ID: 10961259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive.
    Sands K; Jansen R; Zaslau S; Greenwald D
    Aliment Pharmacol Ther; 2015 May; 41(9):821-34. PubMed ID: 25752753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the data on pregnancy and lactation provided by patient information leaflets of anti-rheumatic drugs in Argentina.
    Sabando MO; Saavedra MA; Sequeira G; Kerzberg E
    Rheumatol Int; 2018 Apr; 38(4):669-673. PubMed ID: 29332199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease specific problems related to drug therapy in pregnancy.
    Ostensen M
    Lupus; 2004; 13(9):746-50. PubMed ID: 15485116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends.
    Kardeş S; Kuzu AS; Pakhchanian H; Raiker R; Karagülle M
    Clin Rheumatol; 2021 May; 40(5):2047-2055. PubMed ID: 33130946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.
    Larsen MD; Friedman S; Magnussen B; Nørgård BM
    Am J Gastroenterol; 2016 Nov; 111(11):1608-1613. PubMed ID: 27619836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of biologics and small molecules in pregnant patients with rheumatic diseases.
    Gerosa M; Argolini LM; Artusi C; Chighizola CB
    Expert Rev Clin Pharmacol; 2018 Oct; 11(10):987-998. PubMed ID: 30227748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases.
    Klinger G; Morad Y; Westall CA; Laskin C; Spitzer KA; Koren G; Ito S; Buncic RJ
    Lancet; 2001 Sep; 358(9284):813-4. PubMed ID: 11564493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheumatology drugs and pregnancy.
    Elefant E; Cournot MP; Beghin D; Vauzelle C
    Joint Bone Spine; 2010 Dec; 77(6):506-10. PubMed ID: 20961792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
    Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapies in rheumatologic disorders.
    Miller AV; Ranatunga SK
    Med Clin North Am; 2012 May; 96(3):475-96, ix-x. PubMed ID: 22703852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs in pregnancy. Rheumatological disorders.
    Østensen M
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):953-69. PubMed ID: 11800535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biological disease-modifying anti-rheumatic drugs for pregnant and lactating women or male partners].
    Povlsen K; Skov K; Storgaard L; Andersen SE
    Ugeskr Laeger; 2021 Feb; 183(8):. PubMed ID: 33660603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.